Canté-Barrett, Kirsten

ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia

Peirs, S., Matthijssens, F., Goossens, S., Van de Walle, I., Ruggero, K., de Bock, C. E., Degryse, S., Canté-Barrett, K., Briot, D., Clappier, E., et al. (2014) · Blood

Acute Lymphoblastic Leukemia researchCell death mechanisms and regulation

Cited by 264

MEK and PI3K-AKT inhibitors synergistically block activated IL7 receptor signaling in T-cell acute lymphoblastic leukemia

Canté-Barrett, K., Spijkers-Hagelstein, J. A. P., Buijs-Gladdines, J. G. C. A. M., Uitdehaag, J. C. M., Smits, W. K., van der Zwet, J., Buijsman, R. C., Zaman, G. J. R., Pieters, R., & Meijerink, J. P. P. (2016) · Leukemia

Acute Lymphoblastic Leukemia researchAcute Myeloid Leukemia Research

Cited by 94

Multi-omic analyses in immune cell development with lessons learned from T cell development

Cordes, M., Pike-Overzet, K., Van Den Akker, E. B., Staal, F. J. T., & Canté-Barrett, K. (2023) · Frontiers in Cell and Developmental Biology

Single-cell and spatial transcriptomicsT-cell and B-cell Immunology

Cited by 9